²é¿´: 1887  |  »Ø¸´: 5

Áîºü³å?ÛСÐÜ

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

ħµÀÊ¥¾ý

[½»Á÷] ¡¾2015ÄêFDAÅú×¼ÐÂÒ©»ã×Ü¡¿ ÒÑÓÐ4È˲ÎÓë

FDA Approved new Drugs in 2015


                                                                                                                                                                           date time£º2015-2-10
Cardiology/Vascular Diseases
Prestalia (perindopril arginine and amlodipine besylate); Symplmed Pharmaceuticals; For the treatment of hypertension, Approved January 2015

Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015

Dermatology
Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015

Endocrinology
Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015

Family Medicine
Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015

Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015

Hematology
Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015

Immunology
Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015

Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015

Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015

Infections and Infectious Diseases
Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015

Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015

Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015

Neurology
Duopa (carbidopa and levodopa) enteral suspension ; Abbvie; For the treatment of motor fluctuations in patients with advanced Parkinson's disease, Approved January 2015

Rytary (carbidopa and levodopa) extended-release capsules; Impax Labs; For the treatment of Parkinson's disease, Approved January 2015

Obstetrics/Gynecology (Women¡¯s Health)
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015

Oncology
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015

Pediatrics/Neonatology
Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015

Vaccines
Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

ò§çïҩѧ żµÄ

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

¾ý×Ó²ØÆ÷ÓÚÉí£¬´ýʱ¶ø¶¯£¡
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

³ô±¿±¿

ľ³æ (ÕýʽдÊÖ)

°ô°ô

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
2Â¥2015-02-10 19:46:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÁèÓîÀ׳Ø

³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)

Сľ³æ¿ÆÑдóʹ\(^o^)/~

ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

лл·ÖÏí\(^o^)/~
ÉÏÉÆÈôË®\(^o^)/~2025\(^o^)/~
3Â¥2015-02-11 08:30:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

myktt

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

º¢Ëûµù

лл£¬ÊÕµ½ÁË
ºÏ³ÉÀϰÖ
4Â¥2015-02-11 15:22:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

gatzz_0827

½ð³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015
´óÅúÇÀ·Â¹«Ë¾¿ªÊ¼¼¦¶³ÁË
5Â¥2015-02-12 09:17:37
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Áîºü³å?ÛСÐÜ

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

ħµÀÊ¥¾ý

ÒýÓûØÌû:
5Â¥: Originally posted by gatzz_0827 at 2015-02-12 09:17:37
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015
´óÅúÇÀ·Â¹«Ë¾¿ªÊ¼¼¦¶³ÁË

¶¯×÷¿ìµÄ£¬Ó¦¸ÃÔÚÈýÆÚÁÙ´²Ê±¾Í¿ª¶¯ÁË
¾ý×Ó²ØÆ÷ÓÚÉí£¬´ýʱ¶ø¶¯£¡
6Â¥2015-02-12 09:40:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Áîºü³å?ÛСÐÜ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 0857µ÷¼Á +4 Ò»ll°ë 2026-02-28 5/250 2026-03-02 02:33 by 908055542
[¿¼ÑÐ] ²ÄÁÏѧ˶318Çóµ÷¼Á +11 February_Feb 2026-03-01 13/650 2026-03-01 23:53 by ccp273206157
[¿¼ÑÐ] 0856µ÷¼Á +5 ÁõÃÎ΢ 2026-02-28 5/250 2026-03-01 22:30 by wang_dand
[¿¼ÑÐ] 275Çóµ÷¼Á +3 Ã÷Ô¶Çóѧ 2026-03-01 3/150 2026-03-01 22:29 by Áõ±ø
[˶²©¼ÒÔ°] ²©Ê¿×Ô¼ö +7 ¿ÆÑй·111 2026-02-26 11/550 2026-03-01 22:24 by ÕÜÆ½L
[¿¼ÑÐ] 272Çóµ÷¼Á +6 ÌïÖÇÓÑ 2026-02-28 6/300 2026-03-01 21:40 by ¹«èªåÐÒ£
[¿¼ÑÐ] 274Çóµ÷¼Á +3 cgyzqwn 2026-03-01 6/300 2026-03-01 21:24 by cgyzqwn
[¿¼ÑÐ] 306·Ö²ÄÁϵ÷¼Á +4 chuanzhu´¨Öò 2026-03-01 5/250 2026-03-01 19:48 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] »¯¹¤299·ÖÇóµ÷¼Á Ò»Ö¾Ô¸985Âä°ñ +5 ÎûÎû(*^¦Ø^*) 2026-03-01 5/250 2026-03-01 19:47 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 298Çóµ÷¼Á +6 axyz3 2026-02-28 6/300 2026-03-01 19:00 by 18137688336
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖÐÄÏ´óѧÀíѧ»¯Ñ§ +4 15779376950 2026-03-01 5/250 2026-03-01 19:00 by Fff-1
[¿¼ÑÐ] 295Çóµ÷¼Á +7 19171856320 2026-02-28 7/350 2026-03-01 18:54 by 18137688336
[¿¼ÑÐ] 290Çóµ÷¼Á +9 ²ÄÁÏר˶µ÷¼Á£» 2026-02-28 11/550 2026-03-01 17:21 by sunny81
[¿¼ÑÐ] 285Çóµ÷¼Á +8 ÂúÍ·´óº¹µÄѧÉú 2026-02-28 8/400 2026-03-01 16:47 by caszguilin
[¿¼ÑÐ] 311Çóµ÷¼Á +6 ͤͤͤ01 2026-03-01 6/300 2026-03-01 15:41 by 324616
[¿¼ÑÐ] 298Çóµ÷¼Á +9 È˼äΨÄãÊÇÇå»¶ 2026-02-28 12/600 2026-03-01 14:23 by Ducount.Y
[¿¼ÑÐ] µ÷¼Á +3 ¼òľChuFront 2026-02-28 3/150 2026-03-01 11:46 by ÍõΰҪÉϰ¶°¡
[¿¼ÑÐ] 311Çóµ÷¼Á +9 ÄÏåÈ720 2026-02-28 10/500 2026-03-01 10:55 by sunny81
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +4 °®²Áº¹µÄ¿ÉÀÖ±ù 2026-02-28 4/200 2026-03-01 00:38 by èèÇòalter
[»ù½ðÉêÇë] ÃæÉÏÄ£°å¸Ä²»ÁËÒ³±ß¾à°É£¿ +5 ieewxg 2026-02-25 6/300 2026-03-01 00:10 by addressing
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û